MedPath

A trial to examine the effects of Curcu-Rouge on immunity in the elderly

Phase 2
Conditions
Elderly
Registration Number
JPRN-UMIN000041042
Lead Sponsor
ational Hospital Organization Kyoto Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Persons who fall under any of the following criteria will be excluded from the study. 1)Persons who regularly consume health foods containing curcumin 2)Persons who have a history of allergy to curcumin 3)Persons who are pregnant or breastfeeding 4)Persons who undergoing treatment for malignant tumor 5)Persons who regularly take an antibiotic or steroid 6)Persons who are taking two or more antiplatelet agents or a single antiplatelet agent with another antithrombotic agent (e.g., anticoagulant, EPA agent, prostacyclin agent) 7)Persons who have a history of cerebral hemorrhage and are taking a single antiplatelet agent 8)Persons undergoing home oxygen therapy 9)Persons undergoing dialysis due to renal failure 10)Persons with severe liver dysfunction/cirrhosis 11)Persons with severe cardiac dysfunction (left ventricular ejection fraction less than 20%) 12)In addition, persons for whom the research director or co-researcherinvestigators determine to be inappropriate for participation in this research

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath